Cargando…

Liquid Biopsy in Gastrointestinal Cancers: How Close Are We to Reaching the Clinic?

Detalles Bibliográficos
Autores principales:	Earl, Julie, Kataki, Agapi, Smolkova, Bozena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216095/ https://www.ncbi.nlm.nih.gov/pubmed/37345168 http://dx.doi.org/10.3390/cancers15102831

Ejemplares similares

The Metastatic Process through the Eyes of Epigenetic Regulation: A Promising Horizon for Cancer Therapy
por: Smolkova, Bozena, et al.
Publicado: (2022)

How we will reach a safer community
por: Lee, Jong-Koo
Publicado: (2023)

Warfarin pharmacogenetics: How close are we to clinical practice?
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

How can we reach the target of glucose control in type 1 diabetes?
por: Bloomgarden, Zachary
Publicado: (2023)

Liquid Biopsy in Gastrointestinal Cancers
por: Saini, Aman, et al.
Publicado: (2018)

Virtual Biopsy in Soft Tissue Sarcoma. How Close Are We?
por: Arthur, Amani, et al.
Publicado: (2022)

Analysing How We Reach Clinical Decisions
por: Scadding, J G
Publicado: (1994)

Liquid biopsies in bladder cancer—did we find the Holy Grail for biomarker analyses?
por: Rink, Michael, et al.
Publicado: (2016)

Evolving Clinical Utility of Liquid Biopsy in Gastrointestinal Cancers
por: Jacobson, Richard A., et al.
Publicado: (2019)

Use of liquid biopsies in gastrointestinal cancers
por: Khachfe, Hussein H
Publicado: (2021)

Liquid biopsies for bladder cancer
por: Ward, Douglas G., et al.
Publicado: (2017)

Saliva Based Liquid Biopsies in Head and Neck Cancer: How Far Are We From the Clinic?
por: Patel, Aditi, et al.
Publicado: (2022)

Tubercular Mortality: Have We Reached the Limit?
Publicado: (1914)

Liquid Biopsy and Cancer: An Ongoing Story
por: Di Zazzo, Erika, et al.
Publicado: (2023)

The ‘Lost’ frontier of clinical medicine: Have we reached a point of no return?
por: Dalvi, Bharat
Publicado: (2009)

Liquid biopsy: from discovery to clinical implementation
por: Alix‐Panabières, Catherine, et al.
Publicado: (2021)

Liquid biopsy. A challenge for clinical laboratories
por: Jiménez, Wladimiro
Publicado: (2020)

Clonal Hematopoiesis and Liquid Biopsy in Gastrointestinal Cancers
por: Croitoru, Vlad M., et al.
Publicado: (2022)

Complex Coronary Interventions: Are We Reaching a Plateau?
por: Franchin, Luca, et al.
Publicado: (2022)

Organoids and Liquid Biopsy in Oral Cancer Research
por: Eguchi, Takanori
Publicado: (2020)

Liquid biopsies come of age in lung cancer
por: Christopoulos, Petros
Publicado: (2022)

Liquid Biopsies in Cancer Diagnosis, Monitoring and Prognosis
por: Ulivi, Paola, et al.
Publicado: (2022)

Clinical Islet Xenotransplantation: How Close Are We?
por: van der Windt, Dirk J., et al.
Publicado: (2012)

Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?
por: Heredia-Soto, Victoria, et al.
Publicado: (2021)

Tele-Psychiatry: After Mars, Can we Reach the Unreached?
por: Math, Suresh Bada, et al.
Publicado: (2015)

Sleep breathing disorders: have we reached the tipping point?
por: Suarez-Giron, Monique C., et al.
Publicado: (2018)

Liquid biopsies coming of age: biology, emerging technologies, and clinical translation- An introduction to the JITC expert opinion special review series on liquid biopsies
por: Stewart, Mark D., et al.
Publicado: (2023)

American Health Primers: Long Life, and How to Reach It
por: Richardson, Joseph G.
Publicado: (1879)

Knee Osteoarthritis—How Close Are We to Disease-Modifying Treatment: Emphasis on Metabolic Type Knee Osteoarthritis
por: Lambova, Sevdalina Nikolova
Publicado: (2023)

Liquid Biopsy, an Everchanging Balance between Clinical Utility and Emerging Technologies
por: Cucciniello, Linda, et al.
Publicado: (2022)

Cancer detection: the quest for a single liquid biopsy for all
por: The Lancet Oncology
Publicado: (2020)

Liquid biopsy in colorectal cancer: No longer young, but not yet old
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Application of liquid biopsy for prognostic status of cancers and drug response
por: Marchetti, Dario
Publicado: (2020)

Liquid biopsies in non-small cell lung cancer management: what can we learn from methylation status and mutant allele frequencies?
por: Castellano, Gina M., et al.
Publicado: (2020)

Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies
por: Bertok, Tomas, et al.
Publicado: (2020)

Can we reach a 70% level of herd immunity to return to normality?
por: Lee, Jong-Koo
Publicado: (2021)

Understanding Gastric Cancer Risk Factors: We Need to Close the Gap
por: Hwang, Joo Ha
Publicado: (2018)

Dental Outreach Program – How Effective it is in Reaching Out to the Community
por: Dagli, Rushabh, et al.
Publicado: (2015)

Molecular Screening for Urothelial Cancer: How Close We Are?
por: Michas, Athanasios, et al.
Publicado: (2023)

Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?
por: Mocan, Tudor, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dfinetjqbgctr1lhluucsgkunk